Employer profile
Denver Life Sciences
2 certified H-1B filings across 1 fiscal year.
FY2025 filings
2
FY2025 median
$150k
Top role
Senior Software Developer
2 filings
Top state
CO
2 filings
Denver Life Sciences has filed 2 certified H-1B Labor Condition Applications over FY2025. In FY2025, its median certified base salary was $150k ($150k–$150k interquartile range). The most-filed role is Senior Software Developer (2 filings).
Year-over-year
How Denver Life Sciences hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2025 | 2 | $150k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Senior Software Developer | 2 | $150k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| CO | 2 | $150k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl II
2100%
Frequently asked questions
- Does Denver Life Sciences sponsor H-1B visas?
- Yes. Denver Life Sciences has filed 2 certified H-1B Labor Condition Applications (LCAs) over FY2025. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Denver Life Sciences?
- In FY2025, the median certified H-1B base salary at Denver Life Sciences was $150k, with a 25th–75th percentile range of $150k–$150k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Denver Life Sciences hire H-1B workers for?
- Denver Life Sciences's most-filed H-1B role is Senior Software Developer (2 filings). Its top worksite state is CO.
- How many H-1B filings did Denver Life Sciences submit in FY2025?
- Denver Life Sciences had 2 certified H-1B LCA filings in FY2025.